Contamination of perilymph sampled from the basal cochlear turn with cerebrospinal fluid.
about
Cisplatin and oxaliplatin toxicity: importance of cochlear kinetics as a determinant for ototoxicityIn vitro and in vivo pharmacokinetic study of a dexamethasone-releasing silicone for cochlear implants.Systemic lipopolysaccharide compromises the blood-labyrinth barrier and increases entry of serum fluorescein into the perilymph.Adjudin protects rodent cochlear hair cells against gentamicin ototoxicity via the SIRT3-ROS pathway.Gentamicin administration on the stapes footplate causes greater hearing loss and vestibulotoxicity than round window administration in guinea pigs.Inner ear gene transfection in neonatal mice using adeno-associated viral vector: a comparison of two approaches.Nutrient plasma levels achieved during treatment that reduces noise-induced hearing loss.Therapy of hearing disorders - conservative procedures.Current aspects of hearing loss from occupational and leisure noiseLocalized cell and drug delivery for auditory prostheses.Principles of local drug delivery to the inner ear.Local inner-ear drug delivery and pharmacokinetics.Isosorbide concentration in perilymph of the Guinea pig after oral administration versus that after round window perfusionPerilymph Kinetics of FITC-Dextran Reveals Homeostasis Dominated by the Cochlear Aqueduct and Cerebrospinal Fluid.Perilymph sampling from the cochlear apex: a reliable method to obtain higher purity perilymph samples from scala tympani.Pharmacokinetics of Drug Entry into Cochlear FluidsDemonstration of a longitudinal concentration gradient along scala tympani by sequential sampling of perilymph from the cochlear apex.Perilymph pharmacokinetics of markers and dexamethasone applied and sampled at the lateral semi-circular canal.Permeability of the round window membrane is influenced by the composition of applied drug solutions and by common surgical proceduresConcentration gradient along the scala tympani after local application of gentamicin to the round window membraneEntry of substances into perilymph through the bone of the otic capsule after intratympanic applications in guinea pigs: implications for local drug delivery in humans.A novel vehicle for local protein delivery to the inner ear: injectable and biodegradable thermosensitive hydrogel loaded with PLGA nanoparticles.High concentrations of thiosulfate in scala tympani perilymph after systemic administration in the guinea pig.Cochlear implants and drug delivery: In vitro evaluation of dexamethasone release.Micro-CT analysis of the anatomical characteristics of the stapedial annular ligament.Dexamethasone concentration gradients along scala tympani after application to the round window membrane.Dexamethasone levels and base-to-apex concentration gradients in the scala tympani perilymph after intracochlear delivery in the guinea pig.Cochlear microdialysis for quantification of dexamethasone and fluorescein entry into scala tympani during round window administration.Cochlear pharmacokinetics with local inner ear drug delivery using a three-dimensional finite-element computer model.Cochlear pharmacokinetics of cisplatin: an in vivo study in the guinea pig.The pharmacokinetic profiles of dexamethasone and methylprednisolone concentration in perilymph and plasma following systemic and local administration.Communication pathways to and from the inner ear and their contributions to drug delivery.
P2860
Q24655188-69E66DE4-E131-45D3-BE67-0E6EA40ED0DFQ30316230-002B40B9-651E-4D1A-993D-CDAB99783C02Q30401923-EDDC52E9-CC6B-42FB-BD60-6C86CD60A3C6Q30419038-F4E9D670-512F-4D03-8670-53D931BB4CADQ30429647-A7F4BD84-C580-438C-90B1-23DC4F4C42EEQ30464591-F310CB77-B543-43D2-85BF-7FCFB4A64A68Q30466285-7615D2CB-8D50-40B8-825A-7E6843CE7BF7Q30473039-76DCB4F8-7826-4C12-989B-4109FD476BB6Q30473044-C15A91A8-3EDD-4CD2-89C6-0E9A16BC9DABQ30475885-F71D92F5-B4E9-4DB7-9375-2630DF63943BQ30478838-4F4A953A-3C21-4FE6-BB3E-D59C537F1297Q30489671-474F310F-1851-4032-8B3A-5FD545ACB3ACQ34556727-C89B9AFE-DE99-4A44-8B83-7E62F93A3FF4Q35561882-63352454-AC19-4A89-A525-54D64041B0DFQ35585303-EBE9150C-77DD-45D7-A193-00CE68EC7C79Q35652750-AFB24E2B-C9FF-499B-AA9F-07B6D9720038Q35933593-AD4456E7-F898-44E9-80DB-6BFC3D862D76Q36421098-45242EF7-87EF-4314-B269-471B8FC92E50Q37000346-DD8CFEAD-E0B3-40E4-8047-B8C955E3E154Q37309543-1A85588B-92C4-49F2-AE5E-902C981689B5Q37311062-1BEE10EC-82FE-4230-BD00-AD0E63DD2D9FQ38603485-3CF1B912-EAE1-4D36-9760-2900ABA2E6ABQ39317419-A8C0575C-534D-45A9-AE52-56C5C05CDCD2Q39357184-99571239-7AEC-443E-8677-A1F3ECE3FA32Q39994834-819C0B35-E783-491E-B2AB-AC3286675B4FQ41641420-B6A080DA-73CC-48A1-ACE7-119BF1E0DD17Q41810387-A7C2DF16-6F2A-4E4C-BCDE-5FC141E605BCQ41890379-97F67F04-F84D-4EB5-8363-380F38FC6B2EQ41931676-1C0975AC-406F-464D-8F75-5225DD71E5F6Q42439712-A1F0E943-C901-48B9-8017-BF229D1D9BCFQ46965179-E17CF495-7259-422A-8F41-20675114B619Q47896229-AA7F778D-479A-4CAF-BDE5-0B0445A80C2F
P2860
Contamination of perilymph sampled from the basal cochlear turn with cerebrospinal fluid.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Contamination of perilymph sampled from the basal cochlear turn with cerebrospinal fluid.
@en
Contamination of perilymph sampled from the basal cochlear turn with cerebrospinal fluid.
@nl
type
label
Contamination of perilymph sampled from the basal cochlear turn with cerebrospinal fluid.
@en
Contamination of perilymph sampled from the basal cochlear turn with cerebrospinal fluid.
@nl
prefLabel
Contamination of perilymph sampled from the basal cochlear turn with cerebrospinal fluid.
@en
Contamination of perilymph sampled from the basal cochlear turn with cerebrospinal fluid.
@nl
P1433
P1476
Contamination of perilymph sampled from the basal cochlear turn with cerebrospinal fluid
@en
P2093
Christian Kellner
Shane Hale
P356
10.1016/S0378-5955(03)00137-0
P50
P577
2003-08-01T00:00:00Z